Thiopurine metabolite monitoring in paediatric inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 8, 2007, Pages 941-947

  Ooi, C Y ^a   Bohane, T D ^a   Lee, D ^a   Naidoo, D ^a   Day, A S ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AZATHIOPRINE; DRUG METABOLITE; MERCAPTOPURINE; METHYLMERCAPTOPURINE; TIOGUANINE; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG MONITORING; ENTERITIS; ERYTHROCYTE; FEMALE; HUMAN; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE;

6-MERCAPTOPURINE; ADOLESCENT; AZATHIOPRINE; CHILD; CHILD, PRESCHOOL; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFLAMMATORY BOWEL DISEASES; LEUKOPENIA; LIVER DISEASES; MALE; PANCREATITIS; RETROSPECTIVE STUDIES; THIOGUANINE; THROMBOCYTOPENIA; TREATMENT REFUSAL;

EID: 34047125345     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03278.x     Document Type: Article

References (19)

1. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn's disease: a meta-analysis. Ann Int Med 1995; 123: 132-42.
2. George J, Present DH, Pou R, et al. The long-term outcome of ulcerative colitis treated with 6-mercaptopurine. Am J Gastroenterol 1996; 91: 1711-4.
3. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine for maintenance of remission in Crohn's disease (Cochrane Review). The Cochrane Library Issue 4 2002.
4. Kader HA, Mascarenhas MR, Piccoli DA, et al. Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis. J Pediatr Gastroenterol Nutr 1998; 28: 54-8.
5. Baert F, Norman M, Vermeire S, et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 2003; 348: 601-8.
6. Louis E, Belaiche J. Optimizing treatment with thioguanine derivatives in inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2003; 17: 37-46.
7. Derijks LJJ, Gilissen LPL, Hooymans PM, Hommes DW. Review article: thiopurines in inflammatory bowel disease. Aliment Pharmacol Ther 2006; 24: 715-29.
8. Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000; 118: 705-13.
9. Campbell S, Kingstone K, Ghosh S. Relevance of thiopurine methyltransferase activity in inflammatory bowel disease patients maintained on low-dose azathioprine. Aliment Pharmacol Ther 2002; 16: 389-98.
10. Cuffari C, Hunt S, Bayless T. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease. Gut 2001; 48: 642-6.
11. Lichtenstein GR. Use of laboratory testing to guide 6-mercaptopurine? azathioprine therapy. Gastroenterology 2004; 127: 1558-64.
12. Sies C, Florkowski C, George P, et al. Measurement of thiopurine methyl transferase activity guides dose-initiation and prevents toxicity from azathioprine. N Z Med J 2005; 118: U1324.
13. Sands BE. Crohn's disease. In: Feldman M, Friedman L, Sleisenger M, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management, 7th edn. St Louis: Saunders, 2002:2005-38.
14. Jewell DP. Ulcerative colitis. In: Feldman M, Friedman L, Sleisenger M, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management, 7th edn. St Louis: Saunders, 2002:2039-65.
15. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a Pediatric Crohn's Disease Activity Index. J Pediatr Gastroenterol Nutr 1991; 12: 439-47.
16. Lennard L, Singleton HJ. High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thionosinic acid and 6- methylmercaptopurine metabolites in a single sample. J Chromatogr 1992; 583: 83-90.
17. Rowland K, Lennard L, Lilleyman J. High-performance liquid chromatographic assay of methylthioguanine nucleotide. J Chromatogr 1998; 705: 29-37.
18. Gupta P, Gokhale R, Kirschner BS. 6-mercaptopurine metabolite levels in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001; 33: 450-4.
19. Osterman MT, Kundu R, Lichtenstein GR, Lewis JD. Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis. Gastroenterology 2006; 130: 1047-53.